Pulmonology

Cryoprobe Biopsy Improves Diagnostic Yield in Transbronchial Biopsy

Cryoprobe transbronchial biopsy offers a higher diagnostic yield and improved specimen quality compared to conventional forceps biopsy.

Air Embolism: Two Cases After Percutaneous Lung Biopsy

Two cases highlight the rare but severe complication of air embolism following percutaneous lung biopsy, necessitating prompt recognition and management.

Single Question May Flag Poor Quality Sleep in Patients

A simple, single-item screening question may effectively identify patients experiencing poor quality sleep, facilitating earlier intervention.

Pembrolizumab Reduces Pulmonary AEs vs Chemotherapy in NSCLC

Pembrolizumab monotherapy demonstrated a lower incidence of pulmonary adverse events compared to platinum-based chemotherapy in advanced NSCLC.

Dupilumab Superior to Omalizumab in High-Biomarker Asthma

Dupilumab demonstrated superior efficacy compared to omalizumab in patients with high-biomarker severe asthma, particularly regarding exacerbation rates and lung function.

ATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements

ATS 2026 highlights advancements in nontuberculous mycobacteria (NTM) lung disease, focusing on improved detection, optimized therapy, and patient quality of life.

BRINSUPRI® First Therapy Approved for NCFB at ATS 2026

BRINSUPRI® receives first approval for non-cystic fibrosis bronchiectasis (NCFB), addressing a significant unmet need in chronic respiratory care.

Epithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026

ATS 2026 highlighted epithelial cytokine pathways as a common link in severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and COPD.

Triple Therapy in Asthma: Real-World Evidence Supports Earlier Use

New real-world evidence presented at ATS 2026 indicates that initiating triple therapy earlier in asthma management may improve patient outcomes.